{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:37:59Z","timestamp":1763141879021,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 52-year-old man was admitted to our hospital with lower abdominal and low back pain, and abdomen CT at an outside hospital presented a retroperitoneal mass with left urinary tract obstruction and hydronephrosis. In <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT, the retroperitoneal mass showed intense radioactivity. Subsequently, the patient underwent biopsy of the retroperitoneal mass. The pathological examination showed only fibrous tissue without tumor cells. The patient was finally diagnosed with idiopathic retroperitoneal fibrosis. Our case demonstrated that idiopathic retroperitoneal fibrosis had intense uptake of <jats:sup>68<\/jats:sup>Ga-pentixafor.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004375","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T20:00:54Z","timestamp":1661544054000},"page":"e760-e761","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Intense 68Ga-Pentixafor Activity in Idiopathic Retroperitoneal Fibrosis"],"prefix":"10.1097","volume":"47","author":[{"given":"Qiaoqiao","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, People\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoxue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.2169\/internalmedicine.7142-21","article-title":"Malignant lymphoma mimicking retroperitoneal fibrosis","volume":"60","year":"2021","journal-title":"Intern Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1097\/CM9.0000000000001473","article-title":"Clinical and prognostic features of primary retroperitoneal diffuse large B-cell lymphoma: a single-center experience in China","volume":"134","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"jnumed.121.263693","DOI":"10.2967\/jnumed.121.263693","article-title":"Imaging of C-X-C motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-pentixafor PET","year":"2022","journal-title":"J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-020-00681-7","article-title":"Preliminary evidence of imaging of chemokine receptor-4\u2013targeted PET\/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG","volume":"10","year":"2020","journal-title":"EJNMMI Res"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/gfaa083","article-title":"Idiopathic retroperitoneal fibrosis: an update for nephrologists","volume":"36","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17843286.2019.1609152","article-title":"Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature","volume":"75","year":"2020","journal-title":"Acta Clin Belg"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2015101110","article-title":"Idiopathic retroperitoneal fibrosis","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3324\/haematol.2016.142976","article-title":"Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia","volume":"101","year":"2016","journal-title":"Haematologica"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13550-021-00822-6","article-title":"Investigation of spleen CXCR4 expression by [68Ga]pentixafor PET in a cohort of 145 solid cancer patients","volume":"11","year":"2021","journal-title":"EJNMMI Res"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/RLU.0000000000002258","article-title":"Chemokine receptor 4 expression in primary Sj\u00f6gren\u2019s syndrome","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jcmg.2015.09.007","article-title":"[68Ga]pentixafor-PET\/CT for imaging of chemokine receptor 4 expression after myocardial infarction","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2967\/jnumed.119.234484","article-title":"Imaging inflammation in atherosclerosis with CXCR4-directed 68Ga-pentixafor PET\/CT: correlation with 18F-FDG PET\/CT","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.41024","article-title":"Fibrocytes in chronic periaortitis: a novel mechanism linking inflammation and fibrosis","volume":"71","year":"2019","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:06:23Z","timestamp":1750536383000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004375","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}